Diagnostics
Circulating
tumor
cells
CTC (Circulating tumour cells) are carcinoma cells which have been separated from the carcinoma and they have entered the blood stream where they circulate and show a potential for development of metastatic deposits.
These cells can be isolated and identified, and as a result the interest in their detection has been growing exponentially due to:
- Early detection and establishment of a diagnosis of new carcinomas
- Monitoring the course of the disease of the existing carcinoma
- Prognosis – providing information about the risk of repeated appearance of the “old” carcinoma type which is currently present.
BIOMED AID cooperates with R.G.C.C. group offers general tests for detection of CTCs cells, along with tests of specific carcinoma types, breast carcinoma, carcinoma of the large intestine, malignant melanoma and sarcoma….
R.G.C.C. LABORATORY
R.G.C.C. is a Swiss company whose activity is working with medical genetics, in particular with the genetics of cancer (chemosensitivity and chemoresistance). The primary aim lies in the potential to provide access to most of the information which may be useful in the treatment for cancer patients who seek the best possible personalized and integrated treatment.
The tests are prepared in a simple manner, with peripheral blood samples of 20-40 ml.
The analysis is used to isolate the malignant cells, to determine the type of the cancer and the potential existence of metastatic cells. The severity of the disease is also determined on basis of the number of cells in ml units in the blood, along with the invasiveness of the disease.
Determining what the existing malignant cells are sensitive or resistant to is very important. The sensitivity and resistance shall be determined for all known medicaments and supplements.
BIOMED AID is a representative R.G.C.C. laboratories for the Balkan region.
TESTS
BIOMED AID cooperates with R.G.C.C group offers general tests for detection of CTCs cells, along with tests of specific carcinoma types, breast carcinoma, carcinoma of the large intestine, malignant melanoma and sarcoma….
These tests permit:
1. 1. Detection of early signs of carcinoma in formation.
2. 2. Aid for monitoring of the existing carcinomas.
3. 3. Preparation of an individual profile and about the medications which can be used to treat the carcinoma, and therapeutic methods and natural substances which can be used to obtain the best possible effects from the treatment.
A qualitative analysis shall also be prepared, particularly with a percentual testing of the sensitivity of the medications and the therapy for treatment of the carcinoma, such as: Cytostatics, radiotherapy, onco-hyperthermia, monoclonal antibodies, supplements….